Loading chart…
PRE-MARKET
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynaecology, cardiovascular, blood-related, pain and analgesics, oncology/anti-neoplastics, anti-infectives, vitamins, minerals and nutrients, respiratory, HIV antivirals, Metabolics, gastro, anti-diabetic, neuro, derma, and mRNA vaccine.
Emcure Pharmaceuticals Limited (EMCURE) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The EMCURE share price is ₹2,212.80 (-1.43% today), with a market capitalisation of ₹420B and a price-to-earnings (P/E) ratio of 38.4. MarketRipple tracks the EMCURE investment thesis, the ripple-chain impact of market events on Emcure Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹2,224.20
High
₹2,253.20
Low
₹2,181.10
Prev. Close
₹2,245.00
52W High
₹2,266.40
52W Low
₹1,312.30
Day range
₹2,181.10–₹2,253.20
52-week range
₹1,312.30–₹2,266.40
Volume
231K
P/E
38.4
ROE
21.4%
D/E
0.31
Margin
10.7%
Emcure Pharmaceuticals Limited (NSE: EMCURE) is currently trading at ₹2,212.80 (-1.43%).
Emcure Pharmaceuticals Limited's market capitalization is ₹420B.
Emcure Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 38.4.
Emcure Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Emcure Pharmaceuticals Limited currently reads strongly positive, based on 8 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.